Logo image of BBZA.DE

BB BIOTECH AG-REG (BBZA.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:BBZA - CH0038389992

51.8 EUR
-0.7 (-1.33%)
Last: 1/16/2026, 7:00:00 PM

BBZA.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap2.87B
Revenue(TTM)524.89M
Net Income(TTM)166.10M
Shares55.40M
Float55.10M
52 Week High53.2
52 Week Low25.65
Yearly Dividend2.15
Dividend Yield7.28%
EPS(TTM)3.24
PE15.99
Fwd PE13.5
Earnings (Next)01-23
IPO2006-11-08
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
BBZA.DE short term performance overview.The bars show the price performance of BBZA.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

BBZA.DE long term performance overview.The bars show the price performance of BBZA.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 20

The current stock price of BBZA.DE is 51.8 EUR. In the past month the price increased by 6.69%. In the past year, price increased by 27.74%.

BB BIOTECH AG-REG / BBZA Daily stock chart

BBZA.DE Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to BBZA.DE. When comparing the yearly performance of all stocks, BBZA.DE is one of the better performing stocks in the market, outperforming 87.58% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BB BIOTECH AG-REG / BBZA.DE FAQ

What does BB BIOTECH AG-REG do?

BB Biotech AG provides investment services for biotechnology sector. The company is headquartered in Schaffhausen, Schaffhausen and currently employs 86 full-time employees. The company went IPO on 2006-11-08. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.


Can you provide the latest stock price for BB BIOTECH AG-REG?

The current stock price of BBZA.DE is 51.8 EUR. The price decreased by -1.33% in the last trading session.


How is the ChartMill rating for BB BIOTECH AG-REG?

BBZA.DE has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.